APO RESEARCH · REPORT
Plasma Therapy
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
Product & engineering
Understand the product.
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
Selected research
Industry Growth & Trends
Global Plasma Therapy Industry Growth and Trends Forecast to 2032
Market perspective
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
According to APO Research, the global Plasma Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Plasma Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Plasma Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasma Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasma Therapy.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Plasma Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Plasma Therapy Market by Company
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Plasma Therapy Segment by Type
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Plasma Therapy Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Plasma Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Plasma Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Pure PRP
- Leucocyte-rich PRP
- Leukocyte-rich Fibrin (L-PRF)
Applications
- Orthopedic
- Darmatology
- Cardiac Muscle Injury
- Dental
- Nerve Injury
Companies covered
- Terumo
- Arthrex
- Zimmer Biomet
- DePuy Synthes
- EmCyte
- Regen Lab
- ISTO Biologics
- Cesca Therapeutics
- Weigao
- REV-MED
- Nuo Therapeutics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Plasma Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Plasma Therapy Market Size by Region (2021-2032)
- 1.4.1 Global Plasma Therapy Market Size by Region (2021-2026)
- 1.4.2 Global Plasma Therapy Market Size by Region (2027-2032)
- 1.5 Key Regions Plasma Therapy Market Size (2021-2032)
- 1.5.1 North America Plasma Therapy Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Plasma Therapy Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Plasma Therapy Market Size Growth Rate (2021-2032)
- 1.5.4 South America Plasma Therapy Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Plasma Therapy Market Size Growth Rate (2021-2032)
2 Plasma Therapy Market by Type
- 2.1 Type Introduction
- 2.1.1 Pure PRP
- 2.1.2 Leucocyte-rich PRP
- 2.1.3 Leukocyte-rich Fibrin (L-PRF)
- 2.2 Global Plasma Therapy Market Size by Type
- 2.2.1 Global Plasma Therapy Market Size Overview by Type (2021-2032)
- 2.2.2 Global Plasma Therapy Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Plasma Therapy Market Size Forecasted by Type (2027-2032)
- 2.3 Global Plasma Therapy Market Size by Regions
- 2.3.1 North America Plasma Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Plasma Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Plasma Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Plasma Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Plasma Therapy Market Size Breakdown by Type (2021-2026)
3 Plasma Therapy Market by Application
- 3.1 Type Introduction
- 3.1.1 Orthopedic
- 3.1.2 Darmatology
- 3.1.3 Cardiac Muscle Injury
- 3.1.4 Dental
- 3.1.5 Nerve Injury
- 3.2 Global Plasma Therapy Market Size by Application
- 3.2.1 Global Plasma Therapy Market Size Overview by Application (2021-2032)
- 3.2.2 Global Plasma Therapy Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Plasma Therapy Market Size Forecasted by Application (2027-2032)
- 3.3 Global Plasma Therapy Market Size by Regions
- 3.3.1 North America Plasma Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Plasma Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Plasma Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Plasma Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Plasma Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Plasma Therapy Industry Trends
- 4.2 Plasma Therapy Industry Drivers
- 4.3 Plasma Therapy Industry Opportunities and Challenges
- 4.4 Plasma Therapy Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Plasma Therapy Revenue (2021-2026)
- 5.2 Global Plasma Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Plasma Therapy Key Company Headquarters & Area Served
- 5.4 Global Plasma Therapy Company, Product Type & Application
- 5.5 Global Plasma Therapy Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Plasma Therapy Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Plasma Therapy Players Market Share by Revenue in 2025
- 5.6.3 2025 Plasma Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Terumo
- 6.1.1 Terumo Company Information
- 6.1.2 Terumo Business Overview
- 6.1.3 Terumo Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Terumo Plasma Therapy Product Portfolio
- 6.1.5 Terumo Recent Developments
- 6.2 Arthrex
- 6.2.1 Arthrex Company Information
- 6.2.2 Arthrex Business Overview
- 6.2.3 Arthrex Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Arthrex Plasma Therapy Product Portfolio
- 6.2.5 Arthrex Recent Developments
- 6.3 Zimmer Biomet
- 6.3.1 Zimmer Biomet Company Information
- 6.3.2 Zimmer Biomet Business Overview
- 6.3.3 Zimmer Biomet Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Zimmer Biomet Plasma Therapy Product Portfolio
- 6.3.5 Zimmer Biomet Recent Developments
- 6.4 DePuy Synthes
- 6.4.1 DePuy Synthes Company Information
- 6.4.2 DePuy Synthes Business Overview
- 6.4.3 DePuy Synthes Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 DePuy Synthes Plasma Therapy Product Portfolio
- 6.4.5 DePuy Synthes Recent Developments
- 6.5 EmCyte
- 6.5.1 EmCyte Company Information
- 6.5.2 EmCyte Business Overview
- 6.5.3 EmCyte Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 EmCyte Plasma Therapy Product Portfolio
- 6.5.5 EmCyte Recent Developments
- 6.6 Regen Lab
- 6.6.1 Regen Lab Company Information
- 6.6.2 Regen Lab Business Overview
- 6.6.3 Regen Lab Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Regen Lab Plasma Therapy Product Portfolio
- 6.6.5 Regen Lab Recent Developments
- 6.7 ISTO Biologics
- 6.7.1 ISTO Biologics Company Information
- 6.7.2 ISTO Biologics Business Overview
- 6.7.3 ISTO Biologics Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 ISTO Biologics Plasma Therapy Product Portfolio
- 6.7.5 ISTO Biologics Recent Developments
- 6.8 Cesca Therapeutics
- 6.8.1 Cesca Therapeutics Company Information
- 6.8.2 Cesca Therapeutics Business Overview
- 6.8.3 Cesca Therapeutics Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Cesca Therapeutics Plasma Therapy Product Portfolio
- 6.8.5 Cesca Therapeutics Recent Developments
- 6.9 Weigao
- 6.9.1 Weigao Company Information
- 6.9.2 Weigao Business Overview
- 6.9.3 Weigao Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Weigao Plasma Therapy Product Portfolio
- 6.9.5 Weigao Recent Developments
- 6.10 REV-MED
- 6.10.1 REV-MED Company Information
- 6.10.2 REV-MED Business Overview
- 6.10.3 REV-MED Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 REV-MED Plasma Therapy Product Portfolio
- 6.10.5 REV-MED Recent Developments
- 6.11 Nuo Therapeutics
- 6.11.1 Nuo Therapeutics Company Information
- 6.11.2 Nuo Therapeutics Business Overview
- 6.11.3 Nuo Therapeutics Plasma Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Nuo Therapeutics Plasma Therapy Product Portfolio
- 6.11.5 Nuo Therapeutics Recent Developments
7 North America
- 7.1 North America Plasma Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Plasma Therapy Market Size by Country (2021-2026)
- 7.3 North America Plasma Therapy Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Plasma Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Plasma Therapy Market Size by Country (2021-2026)
- 8.3 Europe Plasma Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Plasma Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Plasma Therapy Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Plasma Therapy Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Plasma Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Plasma Therapy Market Size by Country (2021-2026)
- 10.3 South America Plasma Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Plasma Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Plasma Therapy Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Plasma Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst